American Oncology Network Inc Revenue Growth Rates (AONC), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
American Oncology Network Inc   (AONC)
 

AONC's Revenue Growth by Quarter and Year

American Oncology Network Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AONC Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
4th Quarter December 490.88
3rd Quarter September 470.28
2nd Quarter June 433.98
1st Quarter March 364.34
FY 1,759.48





AONC Revenue fourth quarter 2024 Y/Y Growth Comment
American Oncology Network Inc achieved in the fourth quarter 2024, above Company average Revenue rise of 51.42% year on year, to $ 490.88 millions.

Looking into fourth quarter 2024 results within Medical Equipment & Supplies industry 156 other companies have achieved higher Revenue growth. While American Oncology Network Inc ' s Revenue jump of 51.42% ranks overall at the positon no. 3670 in the fourth quarter 2024.


AONC Revenue ( Y/Y Growth %) 2024
 2023 2022 2021
4th Quarter December 51.42 % 7.92 % - -
3rd Quarter September 39.84 % 13.11 % - -
2nd Quarter June 37.78 % - - -
1st Quarter March 19.96 % - - -
FY   37.55 % 114.01 % - -

Financial Statements
American Oncology Network Inc 's fourth quarter 2024 Revenue $ 490.88 millions AONC's Income Statement
American Oncology Network Inc 's fourth quarter 2023 Revenue $ 324.18 millions Quarterly AONC's Income Statement


AONC Revenue (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
4th Quarter December 4.38 % -3.61 % 1.04 % -
3rd Quarter September 8.36 % 6.78 % - -
2nd Quarter June 19.11 % 3.7 % - -
1st Quarter March 12.39 % 1.11 % - -
FY (Year on Year)   37.55 % 114.01 % - -


Back to AONC Growth rate Comparisons >> Back to AONC Growth rate Comparisons >>


Revenue fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #157
Healthcare Sector #497
Overall #3670

Revenue Y/Y Growth Statistics
High Average Low
39.84 % -4.05 % -47.94 %
 
Revenue fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #157
Healthcare Sector #497
Overall #3670
Revenue Y/Y Growth Statistics
High Average Low
39.84 % -4.05 % -47.94 %
 

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

American Oncology Network Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
180.36 % 30.17 % -61.36 %
(Dec 31 2023)  


AONC's IV. Quarter Q/Q Revenue Comment
American Oncology Network Inc achieved in the IV. Quarter 2024 below company average Revenue growth of 4.38% quarter on quarter, to $ 490.88 millions.

Although the IV. Quarter 2024 Revenue Q/Q growth was lower than the regular , this has been yet encouraging story, as the IV. Quarter surge, eclipses the -3.61% growth in the IV. Quarter a year ago

Within Medical Equipment & Supplies industry 116 other companies have achieved higher Revenue quarter on quarter growth. While American Oncology Network Inc 's Revenue growth quarter on quarter, overall rank is 1764.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #117
Healthcare Sector #350
Overall #1764
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #117
Healthcare Sector #350
Overall #1764
Revenue Q/Q Growth Statistics
High Average Low
180.36 % 30.17 % -61.36 %
(Dec 31 2023)  


AONC's IV. Quarter Q/Q Revenue Comment
American Oncology Network Inc achieved in the IV. Quarter 2024 below company average Revenue growth of 4.38% quarter on quarter, to $ 490.88 millions.

IV. Quarter 2024 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -3.61% in the IV. Quarter a year ago.

Within Medical Equipment & Supplies industry 116 other companies have achieved higher Revenue quarter on quarter growth. While American Oncology Network Inc 's Revenue growth quarter on quarter, overall rank is 1764.


American Oncology Network Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Sep 30 2024)		 12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)		 12 Months Ending
(Dec 31 2023)
Cumulative Revenue 12 Months Ending $ 1,759.48 $ 1,592.78 $ 1,458.81 $ 1,339.79 $ 1,279.19
Y / Y Revenue Growth (TTM) 37.55 % 26.87 % 19.93 % - -
Year on Year Revenue Growth Overall Ranking # 875 # 0 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) 10.47 % 9.18 % 8.88 % 4.74 % 1.89 %
Seq. Revenue Growth (TTM) Overall Ranking # 1661 # 1334 # 0 # 0 # 0


Cumulative Revenue growth Comment
With 37.55% annual Revenue growth, American Oncology Network Inc would report a record annual Revenue rise if the fiscal year would end on Dec 31 2024.

In the Healthcare sector 195 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 875.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 94
Healthcare Sector # 196
Overall # 875

Revenue TTM Y/Y Growth Statistics
High Average Low
37.55 %
 28.12 %
19.93 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 94
Sector # 300
S&P 500 # 1661
Cumulative Revenue growth Comment
With 37.55% annual Revenue growth, American Oncology Network Inc would report a record annual Revenue rise if the fiscal year would end on Dec 31 2024.

In the Healthcare sector 195 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 875.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 94
Healthcare Sector # 196
Overall # 875

Revenue TTM Y/Y Growth Statistics
High Average Low
37.55 %
28.12 %
19.93 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 94
Sector # 300
S&P 500 # 1661




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
AONC's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue rise for the quarter ending Dec 31 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2024
Blueprint Medicines Corporation88.19%$ 88.190 millions
Ac Immune Sa88.19%$ 88.190 millions
Agilon Health Inc 86.69%$ 86.693 millions
Regen Biopharma Inc 86.68%$ 86.678 millions
Genfit S a 85.82%$ 85.821 millions
Harrow Inc 83.83%$ 83.829 millions
Zymeworks Inc 83.33%$ 83.333 millions
Orgenesis Inc 82.42%$ 82.424 millions
Macrogenics Inc 80.53%$ 80.532 millions
Septerna Inc 79.66%$ 79.661 millions
Avricore Health Inc 79.01%$ 79.014 millions
Ideaya Biosciences Inc 78.43%$ 78.435 millions
Argenx Se78.05%$ 78.053 millions
Beone Medicines Ltd 77.78%$ 77.776 millions
Pluri Inc 76.19%$ 76.190 millions
Immucell Corporation75.74%$ 75.741 millions
Protalix Biotherapeutics inc 73.74%$ 73.736 millions
Standard Biotools Inc 73.73%$ 73.726 millions
Rhythm Pharmaceuticals Inc 72.61%$ 72.609 millions
Genedx Holdings Corp 66.30%$ 66.298 millions
Axsome Therapeutics Inc 66.04%$ 66.037 millions
Travere Therapeutics Inc 65.98%$ 65.976 millions
Sarepta Therapeutics Inc 65.94%$ 65.938 millions
Zai Lab Limited65.68%$ 65.684 millions
Eton Pharmaceuticals Inc 62.62%$ 62.617 millions
Aprea Therapeutics Inc 61.34%$ 61.344 millions
Rigel Pharmaceuticals Inc60.92%$ 60.919 millions
Procept Biorobotics Corporation59.55%$ 59.553 millions
Adma Biologics Inc 59.06%$ 59.057 millions
C4 Therapeutics Inc 58.75%$ 58.755 millions


About American Oncology Network Inc Revenue Growth Rates (AONC), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: American Oncology Network Inc (CIK 1839998).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001628280-25-015237
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: American Oncology Network Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.